FDA Drug Application (050212) for TETREX by BRISTOL

Back to FDA Applications sponsored by BRISTOL

Application Number050212
Product Number002
FormCAPSULE;ORAL
DosageEQ 250MG HCL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTETREX
Active IngredientTETRACYCLINE PHOSPHATE COMPLEX



Back to FDA Applications sponsored by BRISTOL